Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Liver Metastases

Trial Information

Liver-PILP First-in-Man

Official Title: First In-vivo Trial of the Liver Percutaneous Isolated Localized Perfusion (PILP) Set for the Treatment of Liver Metastases

Summary

The purpose of this study is to determine whether the PILP-kit can be safely used, within specific performance parameters, to isolate and perfuse the liver with a chemotherapeutic drug for the treatment of patients with unresectable liver metastases.

Phase: N/A

Sponsor: Medical Device Works NV SA

Overall Contacts:

Eric Van Cutsem, Prof MD PhD
+32 16 344218

Locations (3)

Country State City Zip Facility and Contact
Belgium Brussels 1200 University Hospital Louvain Saint-Luc
Marc Van den Eynce, MD
+3227641902
Marc.VandenEynde@UCLouvain.be

Pierre Goffette, Prof MD
Sub-Investigator

Marie-Agnes Docquier, MD
Sub-Investigator

Michel Van Boven, Prof MD
Sub-Investigator

Amine Matta, Prof MD
Sub-Investigator

Audrey Pospiech, MD
Sub-Investigator

Renaud Lhommel, MD
Sub-Investigator
Belgium Ghent 9000 University Hospital Ghent
Luc Defreyne, Prof MD PhD
+3293322937
Luc.Defreyne@UGent.be

Elilsabeth Dhondt, MD
Sub-Investigator

Patrick Wouters, Prof MD Phd
Sub-Investigator

Filip De Somer, Prof RN Phd
Sub-Investigator

Sylvie Rottey, Prof MD PhD
Sub-Investigator
Belgium Leuven 3000 University Hospitals Leuven, Catholic University
Eric Van Cutsem, Prof MD PhD
+32 16 344218
Eric.VanCutsem@uz.kuleuven.ac.be

Chris Verslype, Prof MD Phd
Sub-Investigator

Geert Maleux, Prof MD PhD
Sub-Investigator

Marc Van de Velde, Prof MD PhD
Sub-Investigator

Diethard Monbaliu, Prof MD PhD
Sub-Investigator

NCT ID:NCT01250158

Date Last Changed: March 28, 2013